Home / Publication / Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Publication

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Author(s): Julie Bullock, Tiffany Lin, Sanela Bilic

Year: September 15, 2017

Recommended for you

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Publication

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

MIDD can ease pediatric & rare disease drug loss in Japan

Accelerating Oncology Drug FDA Submission with Project Management Services

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Newsletter sign up

Quick links

Solutions

Contact

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

MIDD can ease pediatric & rare disease drug loss in Japan

Accelerating Oncology Drug FDA Submission with Project Management Services

How Model-informed drug development rescue projects from a risky situation​

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Newsletter sign up

Quick links

Solutions

Contact

How Model-informed drug development rescue projects from a risky situation